Get started
Author

Senthill J Rajappa

ICON 2013: Practical consensus recommendations for hormone receptor-positive Her2-negative advanced or metastatic breastcancer
2014 · PM Parikh, S Gupta, et al. · Indian Journal of Cancer · 14
Clinical profile and outcomes of patients with Stage IV adenocarcinoma of lung: A tertiary cancer center experience
2017 · P Paliwal, S Rajappa, et al. · Indian Journal of Cancer · 7
EGFR testing scenario across 111 centres in India: A questionnaire-based survey.
2017 · Kumar Prabhash, Purvish M. Parikh, et al. · Journal of Clinical Oncology · 4
Ignore molecular oncology at your peril
2014 · PM Parikh, K Prabhash, et al. · Indian Journal of Cancer · 4
Prevalence of germline BRCA1 and BRCA2 mutations and variants among ovarian, primary peritoneal and fallopian tube cancer patients: A multicentre Indian study
2019 · S. Gupta, S. Rajappa, et al. · Annals of Oncology · 3
PDF
P1.01-98 A Phase IIIb Trial of Afatinib in EGFRm+ NSCLC: Analyses of Outcomes in Patients with Brain Metastases or Dose Reductions
2018 · Y. Wu, H. Tu, et al. · Journal of Thoracic Oncology · 3
PDF
Patterns of EGFR testing for lung cancer among tertiary care centers in India.
2015 · Kumar Prabhash, Purvish M. Parikh, et al. · Journal of Clinical Oncology · 2
Effect of nanosomal docetaxel lipid suspension (NDLS) on response rate compared to docetaxel: A randomized phase II study in patients with locally advanced or metastatic breast cancer.
2013 · Ateeq Ahmad, Saifuddin Sheikh, et al. · Journal of Clinical Oncology · 2
Clinical relevance of comprehensive genomic profiling for advanced cancers in India.
2021 · Serena Elizabeth Joseph, Aju Mathew, et al. · Journal of Clinical Oncology · 1
CONCORDANCE study: An observational, multicenter, prospective study to evaluate concordance of detecting EGFR mutations by circulating tumor-free DNA versus tissues biopsy in NSCLC.
2020 · Kumar Prabhash, Bivas Biswas, et al. · Journal of Clinical Oncology · 1
A non-interventional, multicenter study to assess prevalence of BRCA1 and BRCA2 mutation among ovarian, primary peritoneal, and fallopian tube cancer patients in India.
2019 · Rohit Kodagali, Sudeep Gupta, et al. · Journal of Clinical Oncology · 1
Lorlatinib in TKI-naïve patients with advanced ALK-positive non-small cell lung cancer (NSCLC) from India.
2025 · Ullas Batra, Somnath Roy, et al. · Journal of Clinical Oncology
Safety and efficacy of biosimilar TDM-1: A real world retrospective study.
2024 · Divya Gandrala, Krishna Mohan V T Mallavarapu, et al. · Journal of Clinical Oncology
Survival outcomes post radical gastrectomy and D2 lymphadenectomy: Real-world evidence from a tertiary care cancer center.
2024 · Rakesh Pinninti, Kiran Pasham, et al. · Journal of Clinical Oncology
Dendritic Cell Therapy for Patients with Refractory Solid Tumours
2012 · P.P. Bapsy, B. Sharan, et al. · Annals of Oncology
PDF
Works count: 15
Citation count: 42
H-index: 4
I10-index: 1
Year
Topic
Type